Element Biosciences

Series-B+
elementbiosciences.com Biotech & Healthcare San Diego, United States Founded 2017 251-500
Total Funding $823M
Latest Round $175M Series-B+
Last Announced Jun 9, 2026
Investors 14 Backers
Decision Makers 6 Verified

About Element Biosciences

Element Biosciences develops genomic sequencing and multiomics technologies. It makes instruments, reagents, kits, and software for biological research, drug discovery, and diagnostic applications. Its customers are scientists and researchers in fields such as genomics, cancer research, pharmaceutical development, and agricultural biotechnology. Element Biosciences sells its products and provides lab services.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters San Diego, United States
Year Founded 2017
Team Size 251-500
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website elementbiosciences.com
Domain Registered Date Jul 7, 2017

Social & Network Presence

X / Twitter Profile @ElemBio (3.2K followers) Created on Jul 2017
LinkedIn Corporate Not linked

Company Milestones & Timeline

8 Events
  1. Capital Raise

    Raised $175,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $277,000,000 · Series-B+

  3. Capital Raise

    Raised $276,000,000 · Series-B+

  4. Capital Raise

    Raised $80,000,000 · Series-B+

  5. Capital Raise

    Raised $15,000,000 · Series-A

    FinSMEs

  6. Milestone

    X account created (@ElemBio)

    3.2K followers

  7. Milestone

    Website domain registered

    elementbiosciences.com

  8. Milestone

    Company founded

    San Diego, United States

Investors & Backers

14
Counterpoint Global
Fidelity
Foresite Capital
Fusion Fund
Janus Henderson Investors
JS Capital Management
JSCapital
Logos Capital
Meritech Capital
RA Capital Management
Samsung Electronics
T. Rowe Price
Venrock
Wellington Management

Funding History

5 Rounds
Series-B+ · Jun 9, 2026
Series-B+ · Jul 11, 2024
$277,000,000 Source
Series-B+ · Jun 29, 2021
$276,000,000 Source
Series-B+ · Jan 9, 2020
$80,000,000 Source
Series-A · Jun 18, 2019
$15,000,000 FinSMEs

Founders & Leadership

8

Danae Van Oene

Senior Vice President of Global Sales and Support

Work email & phone locked Unlock →

Edwin Hauw

Senior Vice President, Marketing & Product Management

Work email & phone locked Unlock →

Logan Zinser

Vice President Finance

Work email & phone locked Unlock →

Mark Aitkenhead

Chief Commercial Officer (CCO)

Work email & phone locked Unlock →

Matt Kellinger

Founder

Work email & phone locked Unlock →

Michael Previte

Founder

Work email & phone locked Unlock →

Molly He

Founder

Work email & phone locked Unlock →

Steve Potter

Vice President, Human Capital Management

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts